The largest database of trusted experimental protocols

4 protocols using anti cd25 clone m a251

1

Phenotypic Characterization of Melan-A-Specific T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Phenotypic characterization on resting T cell clones was performed on 105 T cells labeled with MELOE-1 and Melan-A tetramers (10 μg/mL) (Recombinant protein facility, SFR Santé, Nantes, France), anti-CD8 (clone BW135/80, Miltenyi Biotec), anti-CD45RO (clone UCHL1, BD Biosciences), anti-CD27 (clone M-T271, BD Biosciences), anti-CD28 (clone CD28.2, BD Biosciences), anti-CD62L (clone DREG-56, BD Biosciences), anti-PD-1 (clone EH12, BD Biosciences), anti-CTLA-4 (clone BNI3, Miltenyi Biotec), anti-BTLA (clone J168–540, BD Biosciences), anti-Tim-3 (clone F38–2E2, eBiosciences) and anti-CD95 (clone DX2, BD Biosciences) specific antibodies. PD-1 expression (Clone EH12, BD Biosciences) was tested on specific T cell clones or sorted T cells at rest and after activation by quadruple labeling with specific tetramers, anti-CD8 and anti-CD25 (clone M-A251, BD Biosciences), as activation marker. All the antibodies were used at a concentration of 5 μg/mL. Vß diversity of sorted Melan-A-specific T cell lines was analyzed by labeling with 24 anti-Vß mAbs included in the IOTest Beta Mark TCR V Kit (Beckman-Coulter, IM3497). All the cytometric analyses were performed on a Facs Canto II (BD Biosciences).
+ Open protocol
+ Expand
2

Immune Checkpoint Expression in Activated CD8+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD8+ T lymphocytes were activated for 12 hours in 96-well plates coated with anti-CD3 Ab (OKT3 clone, CRL-8001, ATCC) at different concentrations ranging from 50 mg/mL to 400 ng/mL. Immune checkpoints (ICs) expression was determined by labeling with anti-PD-1 (Clone EH12, BD Biosciences), anti-TIGIT (Clone A15153G, BioLegend), anti-LAG-3 (Clone 11C3C65, BD Biosciences), anti-Tim-3 (Clone F38-2E2, Biolegend) and anti-KLRG1 (Clone 14C2A07, Biolegend) antibodies. An anti-CD25 (clone M-A251, BD Biosciences) specific-antibody was also used as a T cell activation marker. The expression of the main costimulation molecules was assessed on resting T lymphocytes with anti-CD45RO (clone UCHL1, BD Biosciences), anti-CD28 (Clone CD28.2, BD Biosciences), anti-CD27 (Clone L128, BD Biosciences), anti-CD2 (Clone RPA-2.10, BD Biosciences) and anti-LFA-1 (Clone HI111, BD Biosciences) monoclonal antibodies. All the cytometric analyses were performed on a Facs Canto II (BD Biosciences).
+ Open protocol
+ Expand
3

Monocyte-T Cell Interaction Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were isolated from healthy controls using density centrifugation as described previously. CD4+ T-cells were isolated from the PBMC fraction using the EasySep™ CD4+ T-cell isolation kit (Stemcell Technologies) as per the manufacturer’s instructions. The T-cells were stained with 2µM CellTrace Violet (Invitrogen). A 96-well plate (Eppendorf) was coated with anti-CD3 (1:1000, Clone OKT3, Invitrogen) for 90min. The coating solution was removed prior to use. Wells without coating served as negative controls.
Monocytes from patients or in vitro polarization, as described above, were counted (XN-350, Sysmex) and resuspended in RPMI-1640 supplemented with 10% foetal calf serum, 2mM L-glutamine and PenStrep. Next, monocytes and T-cells at a 1:10 ratio (monocytes:T-cells) were added to the coated plate in a total volume of 200µl. The cells were incubated for 72h, 37°C, at 5% CO2. The cells were detached through gentle pipetting, centrifuged, and stained with anti-CD3 (clone UCHT1, alexa fluor 700, 1:200), anti-CD25 (clone M-A251, PerCP Cy5.51:200), anti-HLA-DR (clone G46-6, APC-H71:200) and anti-CTLA-4 (clone BNI3, PE, 1:50), all from BD, for 25min, RT. Finally, the cells were washed once with PBS and analysed using flow cytometry (CytoFLEX).
+ Open protocol
+ Expand
4

T-Cell Cytotoxicity Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
All cancer cell lines were obtained from the ATCC except for the OVCAR8 cell line, which was obtained from the NCI. Cell lines were passaged a maximum of 36 times after being received from the ATCC. T cells were purified from leukaphereses using EasySep Human T Cell Isolation Kits (STEMCELL Technologies). T-cell killing assays were performed as described previously (27) . Tumor cell viability was measured using CellTiterGlo or by labeling cells with luciferase and measuring luciferase activity. T-cell activation assays were set up using the same conditions as the T-cell killing assays. Cytokines were measured using AlphaLISA kits (Perkin Elmer). CD69 and CD25 expression on T cells was measured by flow cytometry using anti-CD25 clone M-A251 and anti-CD69 clone FN50 antibodies (BD Biosciences).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!